Trump Cooking Up A Sweeping Executive Order That Would Cut Drug Prices In Medicare’s Part D Program, Sources Say
According to reporting from Reuters, sources say the proposal would be much broader than the administration’s previously disclosed proposal to lower prices on physician administered, or Part B, drugs by tying prices to lower costs in other countries.
Exclusive: White House Preparing Order That Would Cut Drug Prices For Medicare-Sources
U.S. President Donald Trump is considering a sweeping executive order that would cut prices on virtually all branded prescription drugs sold to Medicare and other government programs, according to two industry sources who had discussions with the White House. The order under discussion would be much broader than the Administration's previously disclosed proposal to lower prices on physician administered, or Part B, drugs by tying prices to lower costs in other countries. (Erman and O'Donnell, 7/24)
Trump, Azar Meet With Pharma Executives At White House
President Donald Trump hosted pharmaceutical executives in the Oval Office today as his administration pursues a deal on drug pricing, four individuals with knowledge of the meeting told POLITICO. Steve Ubl, the CEO of PhRMA, was joined by representatives of Pfizer and Amgen. HHS Secretary Alex Azar and Domestic Policy Council chief Joe Grogan also attended the meeting, as well as House Majority Leader Kevin McCarthy and Rep. Mark Meadows (R-N.C.). (Diamond and Owermohle, 7/24)